Update on macrophages and innate immunity in scleroderma.
Update on macrophages and innate immunity in scleroderma.
复制标题
硬皮病中巨噬细胞和先天免疫的更新。
DOI:
10.1097/bor.0000000000000218
复制
发表时间:
2015-11
影响因子:
5.1
通讯作者:
Lu TT
中科院分区:
文献类型:
--
作者:
Chia JJ;Lu TT
In this review of the literature from 2014 through mid-2015, we examine new data that sheds light on how macrophages and other innate immune cells and signals contribute to inflammation, vascular dysfunction and fibrosis in scleroderma. Recent human studies have focused on changes early in scleroderma, and linked macrophages to inflammation in skin and progression of lung disease. Plasmacytoid DCs have been implicated in vascular dysfunction. In mice, several factors have been identified that influence macrophage activation and experimental fibrosis. However, emerging data also suggests that myeloid cells can have differential effects in fibrosis. Sustained signaling through different TLRs can lead to inflammation or fibrosis, and these signals can influence both immune and non-immune cells. There are many types of innate immune cells that can potentially contribute to scleroderma and will be worth exploring in detail. Experimentally dissecting the roles of macrophages based on ontogeny and activation state, and the innate signaling pathways in the tissue microenvironment, may also lead to better understanding of scleroderma pathogenesis.